Relapsed/refractory richter transformation

Clinical trials for Relapsed/refractory richter transformation explained in plain language.

Never miss a new study

Get alerted when new Relapsed/refractory richter transformation trials appear

Sign up with your email to follow new studies for Relapsed/refractory richter transformation, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Experimental CAR T-Cell therapy targets rare B-Cell cancers

Disease control Stopped early

This phase 2 study tested a treatment called brexucabtagene autoleucel, a CAR T-cell therapy made from a patient's own immune cells, for four rare B-cell cancers: Waldenstrom macroglobulinemia, Richter transformation, Burkitt lymphoma, and hairy cell leukemia. The trial enrolled …

Matched conditions: RELAPSED/REFRACTORY RICHTER TRANSFORMATION

Phase 2 • Sponsor: Kite, A Gilead Company • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

Relapsed/refractory richter transformation

Get alerted when new Relapsed/refractory richter transformation trials appear

Experimental CAR T-Cell therapy targets rare B-Cell cancers